Parenteral Iron Therapy for Pediatric Patients
Iron deficiency (ID) is by far the most common nutritional disorder in developing and developed countries. When left untreated, ID leads to anemia. Although the usually recommended treatment for iron deficiency anemia (IDA) is oral iron therapy with countless products, such therapy necessitates admi...
Main Authors: | Elpis Mantadakis, Sonia Alexiadou, Panagiota Zikidou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Hemato |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-6357/5/1/5 |
Similar Items
-
Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
by: Guy Rostoker, et al.
Published: (2022-07-01) -
A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01) -
Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis
by: Naser Yamani, et al.
Published: (2021-10-01) -
Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women
by: Jae-Yoon Shim, et al.
Published: (2018-08-01) -
Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease
by: Patricia Garcia-Ortega, et al.
Published: (2022-10-01)